Dec 31, 2023
NCT06158841: Phase 3: Intravenous (IV) ABBV-383 Monotherapy Versus Standard Therapies Relapsed/Refractory Myeloma
NCT06158841: Phase 3: Intravenous (IV) ABBV-383 Monotherapy Versus Standard Therapies RRMM Study Assessing Activity of Intravenous (IV)...
155
Dec 1, 2023
Myeloma UK Publication, intended for UK Audience: Myeloma – An Introduction - Myeloma Essentials
Myeloma UK Publication, intended for UK Audience Myeloma – An Introduction - Myeloma Essentials https://www.myeloma.org.uk/...
175
Dec 1, 2023
NCCN GUIDELINES FOR PATIENTS: MULTIPLE MYELOMA 2023
NCCN GUIDELINES FOR PATIENTS: MULTIPLE MYELOMA 2023 Click here to see patient's guideline book by NCCN. Presented with support from: NCCN...
414
Dec 1, 2023
What is Multiple Myeloma? www.uptodate.com
www.uptodate.com - What is Multiple Myeloma? Patient education: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)...
265
Dec 1, 2023
Explore MCT: Join us in creating the most comprehensive platform for Myeloma Clinical Trials
How to Navigate through MCT Website and find high yield topics. You can also search any topic in search bar to find related posts....
400